Evidence map›Paper›PMID 42238416›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Genomic surveillance of a deeply sampled local population reveals age-specific drivers of RSV transmission.

Jiye Kwon, Ellen M de Vries, Philippe Lemey, Ke Li, Mallery Breban, Kelly Laing, Dave Ferguson, Wade Schulz, Carlos R Oliveira, Louis J Bont and 5 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jiye KwonDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health; New Haven, CT, USA.ORCID 0000-0002-2707-3547
Ellen M de VriesDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health; New Haven, CT, USA.
Philippe LemeyDepartment of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.ORCID 0000-0003-2826-5353
Ke LiDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health; New Haven, CT, USA.
Mallery BrebanDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health; New Haven, CT, USA.
Kelly LaingDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health; New Haven, CT, USA.
Dave FergusonDepartment of Laboratory Medicine, Yale School of Medicine; New Haven, CT, USA.
Wade SchulzDepartment of Laboratory Medicine, Yale School of Medicine; New Haven, CT, USA.ORCID 0000-0002-2048-4028
Carlos R OliveiraDepartment of Pediatrics, Section of Infectious Diseases and Global Health, Yale School of Medicine, New Haven, Connecticut.ORCID 0000-0003-1897-6581
Louis J BontDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health; New Haven, CT, USA.
Virginia E PitzerDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health; New Haven, CT, USA.
Daniel M WeinbergerDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health; New Haven, CT, USA.ORCID 0000-0003-1178-8086
Nathan D GrubaughDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health; New Haven, CT, USA.
Verity HillDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health; New Haven, CT, USA.ORCID 0000-0002-3509-8146
Seth RedmondDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health; New Haven, CT, USA.

Funding

Predicting and monitoring variations in the effects of vaccines against RSVR01AI137093 · NIAID · YALE UNIVERSITY · PI Virginia E Pitzer, Daniel Martin Weinberger · 2018 to 2026
$3.4M
Real-World Effectiveness of Perinatal RSV ImmunoprophylaxisR01AI179874 · NIAID · YALE UNIVERSITY · PI Carlos Rafael Oliveira · 2024 to 2026
$2.5M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysisS10OD030363 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2022 to 2022
$1.2M
NCEZID CDC HHS NU50CK000629NIAID NIH HHS R01 AI137093NIAID NIH HHS R01 AI179874NIH HHS S10 OD030363
6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) disproportionately causes severe infections among infants and older adults, yet the key age group responsible for viral spread to other age groups remains poorly defined. While current immunization approaches effectively reduce disease severity among the most vulnerable, identifying the core drivers of infection is essential to effectively disrupt population-level transmission. By generating 910 whole-genome viral sequences of RSV from all age groups (<1 to 65+ years) in Connecticut, we identified that children aged 12-35 months are the primary drivers of viral transmission to other age groups. This group significantly shapes the genetic diversity of circulating strains. Furthermore, we found that RSV is introduced into the community through frequent and independent entries from other US regions throughout the year, rather than through a single explosive seasonal introduction or long-term local persistence. Ultimately, our findings justify prevention strategies that expand beyond reducing disease burden to actively prioritizing the reduction of transmission and infection.

Identifiers

PMID42238416
PMCPMC13228692

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.